PFSA Profusa, Inc: Long-Term Debt to Capital Coefficient

The use of oxygen sensors in niche research is driving growth, which determines the long-term debt-to-equity trend, where the current level is around 0.00. Profusa Inc (PFSA) generates revenue from the regular replacement of biosensors, ensuring a stable cash flow. High physician confidence in non-invasive monitoring strengthens the position of the brand, which creates high-precision subcutaneous diagnostic systems.

PFSA - Profusa Inc. Long-Term Debt to Equity over the range 07/15/2025 - 10/28/2026

This indicator determines the share of long-term liabilities within the overall capital structure, assessing the company's financial leverage. For Profusa Inc (PFSA), this balance is critical amid the risk of electronics supply chain disruptions in Asia. By analyzing the current long-term debt-to-equity ratio, an investor can see the extent to which business development depends on borrowed funds. An increase in this metric signals heightened risks in the event of export restrictions, while a stable curve confirms the capital's resilience to geopolitical shocks.

Key competitors

Long-Term Loans to Capital Ratio DexCom Inc|Penumbra Corp (PEN) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Novanta Photonics (NOVT)|HAE: Long-Term Debt to Capital|inspiresleep.com - Long-Term Liabilities to Capital|Long-Term Debt to Equity PROCEPT BioRobotics Corporation (PRCT)|CNMD - Long-Term Debt to Capital Coefficient|PLSE: Long-Term Debt to Capital|INMD (InMode MD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc PMI|Long-Term Liabilities to Equity surmodics.com|Eversense - Long-Term Debt to Capital|Long-Term Liabilities to Capital NeuroPace Inc NPCE|Long-Term Debt to Equity Ratio TCMD (Tactile Medical)|SNWV - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Outset Medical, Inc. OM|ELMD - Long-Term Loans to Capital Ratio|LENSAR - Long-Term Debt to Capital|AVITA Medical Inc. (RCEL) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital PROF|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|EDAP TMS S.A. (EDAP) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient APYX (apyxmedical.com)|IceCure Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Pulmonx Corp LUNG|TELA (TELA Bio Corp) - Long-Term Debt to Capital|CTSO - Long-Term Liabilities to Capital|Long-Term Debt to Capital Sensus Healthcare, Inc.|zynex.com (ZYXI) - Long-Term Debt to Capital Ratio|ECOR: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Vicarious Surgical Corp|Long-Term Debt to Capital IINN (Inspira Technologies Oxy)|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. (ICU)|Long-Term Debt to Capital IRIX (IRIDEX)|Intelligent Bio Solutions Inc - Long-Term Debt to Capital|XAIR - Long-Term Debt to Equity|STRATA Skin Sciences (SSKN) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio GlucoTrack GCTK|NanoVibronix Inc. (NAOV) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital VERO (Venus Concept Inc.)|Long-Term Liabilities to Capital NUWE|AEMD: Long-Term Debt to Equity|Long-Term Indebtedness to Equity asensus.com ASXC|Long-Term Debt to Equity Ratio AVGR (Avinger, Inc)|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Long-Term Debt to Capital CUTR (Cutera, Inc.)|KNW: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Inari Medical (NARI)|NVRO (Nevro Corp) - Long-Term Liabilities to Equity|Long-Term Debt to Equity RSLS|Long-Term Debt to Equity Ratio Silk Road Medical Inc